NCT00371566View on ClinicalTrials.gov

A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
DRUG

Lapatinib oral tablets

DRUG

Placebo

Trial Locations (9)

14076

GSK Investigational Site, Caen

28041

GSK Investigational Site, Madrid

34298

GSK Investigational Site, Montpellier

94805

GSK Investigational Site, Villejuif

560029

GSK Investigational Site, Bangalore

142 33

GSK Investigational Site, Athens

695 011

GSK Investigational Site, Thiruvananthapuram

Lima 34

GSK Investigational Site, Lima

08035

GSK Investigational Site, Barcelona

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00371566 - A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | Biotech Hunter | Biotech Hunter